Showing results (141-150 of 692) with videos related to
Sort By:
Pageof 70
American Journal of Diseases of Children (1960)|August 1, 1982
Reversible hypertrophic osteoarthropathy associated with cyanotic congenital heart diseaseM Frand, G Koren, Z RubinsteinTherapeutic Drug Monitoring|April 29, 1998
A model for the prediction of digoxin-drug interactions at the renal tubular cell levelC Woodland, S Ito, G KorenDrug Safety|January 1, 1991
Deferoxamine (desferrioxamine). New toxicities for an old drugY Bentur, M McGuigan, G KorenDevelopmental Pharmacology and Therapeutics|January 1, 1992
Comparison of methods for prediction of nephrotoxicity during developmentJ Klein, G Koren, S M MacLeodThe Journal of Pharmacology and Experimental Therapeutics|May 1, 1994
Human placental transfer and metabolism of p-aminobenzoic acidL O Derewlany, B Knie, G KorenReproductive Toxicology (Elmsford, N.Y.)|January 1, 1994
Use of the Retinoid Pregnancy Prevention Program in Canada: patterns of contraception use in women treated with isotretinoin and etretinateA Pastuszak, G Koren, M J RiederCanadian Family Physician Medecin De Famille Canadien|July 13, 2000
Occupational exposure to mercury. What is a safe level?R Moienafshari, B Bar-Oz, G KorenCanadian Family Physician Medecin De Famille Canadien|May 9, 2001
Leflunomide: new antirheumatic drug. Effect on pregnancy outcomesE Kozer, M E Moretti, G KorenLife Sciences|January 1, 1988
The dissociation between aminoglycoside serum concentrations and nephrotoxicityG Koren, J Klein, S M MacLeodClinics in Perinatology|September 1, 1994
Drug transfer across the placenta. Considerations in treatment and researchC Simone, L O Derewlany, G KorenPageof 70